(Q46438885)

English

Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Erich Blase

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

Kristin Taylor

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

Hong-Ye Gao

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

Matthew Wintle

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

Mark Fineman

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

45

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

570-577

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

GLP-1 inhibits gastric emptying of water but does not influence plasma

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Effect of altered gastric emptying and gastrointestinal motility on metformin absorption

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

The influence of gastric emptying on droxicam pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

The action of cisapride on gastric emptying and the pharmacodynamics and pharmacokinetics of oral diazepam

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

The influence of gastrointestinal transit on drug absorption in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Influence of Simulated Weightlessness on the Oral Pharmacokinetics of Acetaminophen as a Gastric Emptying Probe in Man: A Plasma and a Saliva Study

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Clinical pharmacokinetics of paracetamol

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Gastric emptying in diabetes: clinical significance and treatment.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Gastric emptying in diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Highly variable gastric emptying in patients with insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Pharmacokinetic drug interactions with gastrointestinal motility modifying agents

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270004274432

21 January 2018

Identifiers

10.1177/0091270004274432

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15831781

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46438885&oldid=2111729509"